Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Imai
P2.04-16 Correlation Between Programmed Death Ligand 1(pd-L1) Expression and Solid Component on HRCT in Stage I Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
D111 Evaluation of Exposure to Pyrethroid Pesticides Using Urinary Metabolites Among Pesticide Spraying Workers(Oral Presentation,Occupational Health in the Age of Decentralization Reform in Japan,The 79th Annual Meeting of Japan Society for Occupational Health)
Sangyo eiseigaku zasshi = Journal of occupational health
Medicine
Environmental
Public Health
Toxicology
Occupational Health
Related publications
P2.04-01 Associations Histological Subtype of Lung Adenocarcinoma and Programmed Death Ligand 1 (PD-L1) Expression in Tumor Cells.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
Journal of Cancer
Oncology
P2.04-04 Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
Frontiers in Oncology
Cancer Research
Oncology
Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors
Asian Pacific Journal of Cancer Prevention
P2.04-05 Correlation Between PD-L1 Gene Promoter Polymorphisms and Expression of PD-L1 mRNA and Protein in NSCLC Patients.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Quantitative and Pathologist-Read Comparison of the Heterogeneity of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer
Modern Pathology
Forensic Medicine
Pathology
2241. Outcomes of Program Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1(pd-L1) Inhibitor Therapy in HIV Patients With Advanced Cancer
Open Forum Infectious Diseases
Oncology
Neurology
